Listed Issuer Financing Exemption (LIFE): How It Works
The listed issuer financing exemption lets Canadian listed issuers sell freely tradeable shares to retail investors with a short offering document instead of a prospectus. A 2025 blanket order raised the limit to the greater of CAD 25 million and 20% of market value, capped at CAD 50 million, and the CSA has proposed codifying it.

Key takeaways
- LIFE requires 12 months as a reporting issuer, listed equity and current continuous disclosure.
- NI 45-106 caps LIFE at the greater of CAD 5 million and 10% of market value, to CAD 10 million.
- Blanket Order 45-935 raises the cap to the greater of CAD 25 million and 20%, to CAD 50 million.
- Form 45-106F19 plus 12 months of filings must disclose all material facts.
- Securities are generally free trading; closing must occur within 45 days of the news release.
What is the listed issuer financing exemption?
The listed issuer financing exemption (LIFE) lets a Canadian listed reporting issuer sell freely tradeable shares, or units of shares and warrants, to any investor, including retail investors, without a prospectus. Instead, the issuer relies on its continuous disclosure record plus a short offering document, Form 45-106F19. The exemption is in Part 5A of National Instrument 45-106 Prospectus Exemptions and has become a mainstream financing tool. Since 15 May 2025, coordinated blanket orders have allowed much larger offerings than the instrument itself permits, and in July 2026 the Canadian Securities Administrators (CSA) proposed to make those higher limits permanent.

For small and mid-cap issuers on the TSX, TSX Venture Exchange and Canadian Securities Exchange, LIFE fills a gap between expensive prospectus offerings and private placements limited to accredited investors with four-month hold periods. This note explains eligibility, the dollar and dilution limits, the offering document, liability, resale treatment and a practical timetable.
Eligibility conditions
Under s. 5A.2 of NI 45-106, the listed issuer financing exemption is available only if all of the following apply:
- the issuer has been a reporting issuer in at least one Canadian jurisdiction for the 12 months before it files the news release announcing the offering;
- it has equity securities listed on a recognized Canadian exchange;
- it is not, and during the previous 12 months was not, an issuer whose operations have ceased or whose principal asset is cash, cash equivalents or its exchange listing, such as a capital pool company or special purpose acquisition company;
- it is not an investment fund;
- it has filed all required periodic and timely disclosure documents;
- it will not use the proceeds for a significant acquisition, a restructuring transaction, or any other transaction requiring security holder approval;
- it reasonably expects to have enough funds to meet its business objectives and liquidity requirements for the 12 months after the distribution;
- the securities are listed equity securities, or units of listed equity securities and warrants convertible into listed equity securities.
The 12-month working capital condition is often the practical constraint. An issuer that needs the money simply to survive may not be able to rely on LIFE. Boards should document the basis for their expectation, including the budget, committed funding and the minimum offering size needed to meet the test, because the condition is assessed at the time of the distribution and a regulator may later ask how it was satisfied.
Dollar and dilution limits, and the 2025 blanket order
Under the instrument itself, the total raised under the listed issuer financing exemption in any 12-month period may not exceed the greater of CAD 5,000,000 and 10% of the aggregate market value of the issuer's listed securities, to a maximum of CAD 10,000,000, and the offerings may not increase the issuer's outstanding listed equity securities by more than 50% (s. 5A.2(g) and (h)).
Coordinated Blanket Order 45-935, effective 15 May 2025, varies those conditions for issuers that meet additional requirements. According to the CSA announcement and the BCSC version of the order:
| Condition | NI 45-106 Part 5A | Blanket Order 45-935 |
|---|---|---|
| 12-month dollar limit | Greater of CAD 5 million and 10% of market value, capped at CAD 10 million | Greater of CAD 25 million and 20% of market value, capped at CAD 50 million |
| Dilution limit | No more than 50% increase in listed equity securities over 12 months | No more than 50%, counting warrants convertible within 60 days of closing |
| Control | No specific condition | No new control person; no person able to elect a majority of directors |
| Cover page statement | Standard Form 45-106F19 statement | Bold statement that the issuer relies on the order and its higher limit |
In some jurisdictions the blanket order has an expiry date based on local term limits for blanket orders. On 23 July 2026 the CSA published proposed amendments that would codify the higher limits in NI 45-106 and streamline other conditions; according to the CSA release, the 2025 order facilitated CAD 3.7 billion in capital raised in its first year, and the 90-day comment period closed on 21 October 2026. Until the amendments are adopted, issuers should check the order in each jurisdiction where they distribute.
The Form 45-106F19 offering document
Before soliciting any offer to purchase, the issuer must issue and file a news release announcing the offering with a prescribed statement directing investors to the offering document, file a completed Form 45-106F19 Listed Issuer Financing Document, and post it on its website if it has one (s. 5A.2(k)). The form must be filed no later than three business days after its date. In Quebec, it must be in French or in French and English.
The form is short and covers the offering, the issuer's business, recent developments, material facts, available funds and their use, compensation paid to dealers and finders, and the purchaser's rights. But brevity is deceptive. Under s. 5A.2(m), the form, together with the issuer's continuous disclosure documents filed in the previous 12 months (or since its last audited annual financial statements, if earlier), must contain disclosure of all material facts relating to the securities and must not contain a misrepresentation. The continuous disclosure record therefore has to be current and accurate.
Run a disclosure review before announcing a LIFE offering, as you would before a short-form prospectus. If a material change has occurred and has not been reported, or the MD&A is stale, fix it first. A misrepresentation in the record is a misrepresentation in the offering.
Liability for misrepresentation
Purchasers under the listed issuer financing exemption have statutory remedies for misrepresentation. Section 5A.5 of NI 45-106 designates the completed Form 45-106F19 as a prescribed offering document or disclosure document for the purposes of specified provisions of the Alberta, British Columbia, New Brunswick and Quebec securities statutes, and secondary market civil liability provisions apply across Canada through the issuer's continuous disclosure record. The form must describe purchasers' rights of action. Directors and officers who sign or approve the document, and the issuer, face potential liability, which is a further reason for diligence comparable to a short-form prospectus offering.
Material changes during the offering period also matter. Under s. 5A.3, if a material change occurs after the news release and before completion, the issuer must disclose the change, file an amendment to the completed Form 45-106F19 and meet the other requirements of that section before completing the distribution, which can delay closing.
Free-trading securities and resale
A major advantage of the listed issuer financing exemption over the accredited investor exemption is resale treatment. Securities issued under LIFE are subject only to a seasoning period under NI 45-102, not to the four-month restricted period that applies to most private placements; because LIFE issuers must already have been reporting issuers for 12 months, the securities are generally freely tradeable on issuance. That makes LIFE attractive to retail investors and allows dealers to market offerings more broadly. Our note on resale restrictions on private placements explains the contrast.
A practical timetable
- Preparation (one to two weeks). Disclosure review, working capital analysis, dealer or finder engagement, exchange pre-clearance where required, and drafting of the news release and Form 45-106F19.
- Launch. Issue and file the news release, file the form and post it on the website before soliciting.
- Marketing and subscriptions. Dealers may solicit investors, including retail, using the form. Investors complete subscription agreements.
- Closing. The distribution must close no later than the 45th day after the news release is issued and filed (s. 5A.3(2)).
- Post-closing. File a report of exempt distribution and the exchange's closing documents, and issue a closing news release.
Exchange rules apply in parallel. The TSX, TSX Venture Exchange and Canadian Securities Exchange each have pricing, shareholder approval and notice requirements for private placements and prospectus-exempt offerings, which may require approval if insiders participate significantly or if dilution exceeds exchange thresholds.
Dealers, finders and insiders
Most offerings under the listed issuer financing exemption are marketed by registered investment dealers, which must meet their own know-your-client and suitability obligations when selling to retail clients. Finders who are not registered must be careful not to engage in the business of trading; paying finders' fees to unregistered persons who solicit investors can breach registration requirements. Compensation paid to dealers and finders, including broker warrants, must be disclosed in the offering document.
Insiders often want to participate. LIFE does not prohibit insider participation, but exchange rules and, where applicable, MI 61-101 related-party requirements may require disclosure, approval or valuation exemptions, and the blanket order's conditions bar distributions that create a new control person. Issuers should map insider participation early so that the structure stays within both the exemption and exchange limits.
Common compliance errors
- Soliciting investors before the news release and Form 45-106F19 are filed and posted.
- Miscalculating the 12-month dollar or dilution limit by overlooking earlier LIFE offerings or warrants.
- Using proceeds for a significant acquisition that was not disclosed as part of the plan.
- Relying on a stale continuous disclosure record with unreported material changes.
- Missing the 45-day closing deadline after a slow marketing period.
- Failing to prepare the French version for Quebec purchasers.
When to use the listed issuer financing exemption
LIFE works best for issuers with a clean disclosure record, a clear use of proceeds, enough funding to satisfy the 12-month test, and a retail shareholder base or dealer network able to reach retail investors. It is less suited to transformational financings tied to acquisitions, issuers that need a control investor, or issuers whose disclosure needs significant updating. Alternatives include bought deals and marketed offerings under a short-form prospectus, the accredited investor exemption, the offering memorandum exemption and the existing security holder exemption. Our note on the offering memorandum exemption compares options for issuers that are not listed.
Illustration: a TSX Venture-listed mineral explorer with a CAD 120 million market capitalization wants to raise CAD 20 million for a drill programme. Under the instrument alone it could raise only CAD 10 million in 12 months. Relying on Blanket Order 45-935, the greater of CAD 25 million and 20% of market value (CAD 24 million) allows the full offering, provided no new control person emerges and dilution stays within 50%.
How TRW & Co helps
We advise listed issuers and dealers on offerings under the listed issuer financing exemption: eligibility and blanket order analysis, disclosure reviews, drafting the news release and Form 45-106F19, exchange approvals, insider participation and closing filings. We also compare LIFE with prospectus and other exempt routes. See our pages on prospectus-exempt financings and continuous disclosure. This note is general information, not legal advice. To plan an offering, contact us.
Frequently asked questions
Who can use the listed issuer financing exemption?
A reporting issuer that has been reporting for at least 12 months, has equity securities listed on a recognized Canadian exchange, is not a shell, CPC, SPAC or investment fund, is current in its filings, will not use proceeds for a significant acquisition or restructuring, and expects to have enough funds for the next 12 months.
How much can be raised under LIFE in 2026?
Under NI 45-106 itself, the greater of CAD 5 million and 10% of market value, up to CAD 10 million, in 12 months. Under Coordinated Blanket Order 45-935, effective 15 May 2025, eligible issuers can raise the greater of CAD 25 million and 20% of market value, up to CAD 50 million, subject to conditions including a 50% dilution cap and no new control person.
Are LIFE securities subject to a four-month hold?
No. Securities issued under the exemption are subject only to a seasoning period under NI 45-102, which issuers that have been reporting for 12 months already satisfy, so the securities are generally freely tradeable on issuance, unlike most private placement securities.
Can investors sue for misrepresentation in a LIFE offering?
Yes. The Form 45-106F19 is designated for statutory liability purposes in several provinces, secondary market liability applies to the continuous disclosure record, and the form must describe purchasers' rights. Issuers and their directors should conduct diligence similar to a short-form prospectus offering.
Will the higher LIFE limits become permanent?
The CSA proposed on 23 July 2026 to codify the higher limits in NI 45-106 and streamline other conditions, with comments due by 21 October 2026. Until the amendments are adopted, issuers rely on the blanket order in each jurisdiction, some of which have expiry dates.
Sources
General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.


